type in your search and press enter
Montreal’s Four Leading Pediatric Institutions Begin Largest Collaboration in Canadian History to Help Children with Musculoskeletal Disorders
You May Also Like
New analysis of Novartis Phase III brolucizumab (RTH258) data reinforces superior reduction of retinal fluid, a key marker of disease activity in nAMD
Pre-specified analysis provides insight into maintenance treatment effectiveness with like-for-like comparison of brolucizumab versus ...
UroGen Pharma’s Chairman, Arie Belldegrun, MD, FACS to Receive EY 2018 Master Entrepreneur Award
RA’ANANA, Israel and NEW YORK, June 13, 2018 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. ...
Landmark Study Shows GeneSight® Test Led to Significant Improvement in Mental Health Outcomes for Patients with Major Depressive Disorder
Data Presented at APA Show 50 Percent Improvement in Remission and 30 Percent Improvement ...
